Advocates view $26billion opioid deal with frustration, worry

Four major drug companies agreed to a $26billion settlement last week to end lawsuits over the opioid crisis, but treatment advocates expressed frustration that the money will be slow to arrive and worry it could be misspent, Reuters reveals.